Medical News

RSS

Cancer specialist outlines 10 symptoms that should never be ignored

Patients often ask, "Doc, is this something to worry about?" Patients fear the worst yet often choose to ignore potentially deadly warning signs.

29 Sep 2014

President of DonnaCardillo.com to deliver keynote presentation at NNBA Conference

As healthcare evolves to meet the changing demographics and health needs of the population, so too does the role of the nurse.

29 Sep 2014

Dabrafenib shows significant anti-tumour activity in BRAF V600E mutant non-small cell lung cancer

The BRAF inhibitor dabrafenib has significant anti-tumour activity in patients with advanced BRAF V600E mutant non-small cell lung cancer whose disease has progressed after chemotherapy, according to phase II data presented at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Scientists show how individual neurons in the human brain react to morphed faces

An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.

29 Sep 2014

OSU engineers develop simple device to improve hand function after surgery

Engineers at Oregon State University have developed and successfully demonstrated the value of a simple pulley mechanism to improve hand function after surgery.

29 Sep 2014

Lpath closes $12.5 million registered direct offering

Lpath, Inc., the industry leader in bioactive lipid-targeted therapeutics, announced today the closing of its previously announced $12.5 million registered direct offering.

29 Sep 2014

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2014.

29 Sep 2014

Aptose joins Beat AML research collaboration

Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.

29 Sep 2014

New AliveECG app provides patients with free real-time AF detection in ECG recordings

AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in ECG recordings using its new FDA-cleared algorithm.

29 Sep 2014

Survey: Many patients not always well informed about treatment options

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

29 Sep 2014

Report: Too few staff to care for children admitted to intensive care units

More children than ever are being admitted to intensive care units in England and Wales but there are fewer staff per bed available to cope with the increase, according to a new report published jointly by the University of Leeds and University of Leicester.

29 Sep 2014

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

Myriad Genetics, Inc. today announced that its Tumor BRACAnalysis CDx- companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in women with ovarian cancer. Data from this new study were presented at the 2014 European Society for Medical Oncology annual meeting in Madrid, Spain.

29 Sep 2014

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.

29 Sep 2014

Scientists reveal that human brain can trigger random behavior

Many of the choices we make are informed by experiences we've had in the past. But occasionally we're better off abandoning those lessons and exploring a new situation unfettered by past experiences.

29 Sep 2014

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.

29 Sep 2014

Research points to remote monitoring as offering way to improve patient care

An aging population and an increased incidence of debilitating illnesses such as Parkinson's and Alzheimer's disease means there is pressure on technology to offer assistance with healthcare - monitoring and treatment. Research published in the International Journal of Ad Hoc and Ubiquitous Computing points to remote monitoring as offering a way to improve patient care and even accelerate medical research.

29 Sep 2014

Early detection of cancers on the horizon with supersensitive nanodevice

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville in collaboration with The Joint School of Nanoscience and Nanoengineering in Greensboro, NC.

29 Sep 2014

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Scientists have discovered a previously unknown mechanism by which estrogen prepares cells to divide, grow and, in the case of estrogen-positive breast cancers, resist cancer drugs. The researchers say the work reveals new targets for breast cancer therapy and will help doctors predict which patients need the most aggressive treatment.

29 Sep 2014

Coffee consumption associated with increase in life years, reduction in healthcare costs

Xcenda, the strategic consulting arm of AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution service companies, recently conducted the first-ever health economic analysis on coffee consumption.

29 Sep 2014

Medical News

Cancer specialist outlines 10 symptoms that should never be ignored

President of DonnaCardillo.com to deliver keynote presentation at NNBA Conference

Dabrafenib shows significant anti-tumour activity in BRAF V600E mutant non-small cell lung cancer

Scientists show how individual neurons in the human brain react to morphed faces

OSU engineers develop simple device to improve hand function after surgery

Lpath closes $12.5 million registered direct offering

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Aptose joins Beat AML research collaboration

New AliveECG app provides patients with free real-time AF detection in ECG recordings

Survey: Many patients not always well informed about treatment options

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

Report: Too few staff to care for children admitted to intensive care units

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

Scientists reveal that human brain can trigger random behavior

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

Research points to remote monitoring as offering way to improve patient care

Early detection of cancers on the horizon with supersensitive nanodevice

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Coffee consumption associated with increase in life years, reduction in healthcare costs

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News